MedPath
NMPA Approval

Meloxicam Injection (Ⅱ)

国药准字H20250012

April 30, 2025

Drug Information

美洛昔康注射液(Ⅱ)

注射剂

1ml:30mg

化学药品

April 30, 2025

Company Information

Applicant Company

江苏省南京市江宁区丽泽路99号3幢509、510室(江宁高新园)

Manufacturing Company

南京高新技术产业开发区学府路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

美洛昔康注射液(Ⅱ) - NMPA 批准文号 | MedPath